{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hymenolepis diminuta : Questions médicales les plus fréquentes",
"headline": "Hymenolepis diminuta : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hymenolepis diminuta : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hymenolepis diminuta"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hymenolepis",
"url": "https://questionsmedicales.fr/mesh/D006926",
"about": {
"@type": "MedicalCondition",
"name": "Hymenolepis",
"code": {
"@type": "MedicalCode",
"code": "D006926",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.050.500.500.736.215.454"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hymenolepis diminuta",
"alternateName": "Hymenolepis diminuta",
"code": {
"@type": "MedicalCode",
"code": "D048190",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Derek M McKay",
"url": "https://questionsmedicales.fr/author/Derek%20M%20McKay",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Pharmacology, Calvin, Joan, and Phoebe Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Anna Sulima-Celińska",
"url": "https://questionsmedicales.fr/author/Anna%20Sulima-Celi%C5%84ska",
"affiliation": {
"@type": "Organization",
"name": "Department of General Biology and Parasitology, Medical University of Warsaw, Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Daniel Młocicki",
"url": "https://questionsmedicales.fr/author/Daniel%20M%C5%82ocicki",
"affiliation": {
"@type": "Organization",
"name": "Department of General Biology and Parasitology, Medical University of Warsaw, Warsaw, Poland. daniel.mlocicki@wum.edu.pl."
}
},
{
"@type": "Person",
"name": "Uriel Koziol",
"url": "https://questionsmedicales.fr/author/Uriel%20Koziol",
"affiliation": {
"@type": "Organization",
"name": "Sección Biología Celular, Facultad de Ciencias, Universidad de la República, Montevideo 11400, Uruguay. Electronic address: ukoziol@gmail.com."
}
},
{
"@type": "Person",
"name": "Chaoqun Yao",
"url": "https://questionsmedicales.fr/author/Chaoqun%20Yao",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences and One Health Center for Zoonoses and Tropical Veterinary Medicine, Ross Unive rsity School of Veterinary Medicine, P.O. Box 334, Basseterre, St. Kitts and Nevis."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of an enterprise controlled substance management system on labor and inventory costs.",
"datePublished": "2024-10-26",
"url": "https://questionsmedicales.fr/article/39460665",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/ajhp/zxae305"
}
},
{
"@type": "ScholarlyArticle",
"name": "ParalichenysinDY4, a novel bacteriocin-like substance, is employed to control Clostridium perfringens.",
"datePublished": "2024-09-06",
"url": "https://questionsmedicales.fr/article/39245094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijbiomac.2024.135412"
}
},
{
"@type": "ScholarlyArticle",
"name": "Childhood exposure to per- and polyfluoroalkyl substances and neurodevelopment in the CHARGE case-control study.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36108719",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.envres.2022.114322"
}
},
{
"@type": "ScholarlyArticle",
"name": "Structural instability and linear allocation control in generalized models of substance use disorder.",
"datePublished": "2024-03-02",
"url": "https://questionsmedicales.fr/article/38438105",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mbs.2024.109169"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of controlled drugs and new psychoactive substances (NPS) regulations in East and Southeast Asia.",
"datePublished": "2023-01-12",
"url": "https://questionsmedicales.fr/article/36642324",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.yrtph.2023.105338"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Animaux",
"item": "https://questionsmedicales.fr/mesh/D000818"
},
{
"@type": "ListItem",
"position": 4,
"name": "Invertébrés",
"item": "https://questionsmedicales.fr/mesh/D007448"
},
{
"@type": "ListItem",
"position": 5,
"name": "Helminthes",
"item": "https://questionsmedicales.fr/mesh/D006376"
},
{
"@type": "ListItem",
"position": 6,
"name": "Plathelminthes",
"item": "https://questionsmedicales.fr/mesh/D010986"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cestoda",
"item": "https://questionsmedicales.fr/mesh/D002589"
},
{
"@type": "ListItem",
"position": 8,
"name": "Hymenolepis",
"item": "https://questionsmedicales.fr/mesh/D006926"
},
{
"@type": "ListItem",
"position": 9,
"name": "Hymenolepis diminuta",
"item": "https://questionsmedicales.fr/mesh/D048190"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hymenolepis diminuta - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hymenolepis diminuta",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hymenolepis diminuta",
"description": "Comment diagnostiquer une infection par Hymenolepis diminuta ?\nQuels tests sont utilisés pour confirmer l'infection ?\nQuels symptômes peuvent indiquer une infection ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nQuelle est la méthode de référence pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hymenolepis diminuta",
"description": "Quels sont les symptômes courants d'une infection ?\nL'infection peut-elle être asymptomatique ?\nLes enfants sont-ils plus touchés par les symptômes ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes peuvent-ils varier selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hymenolepis diminuta",
"description": "Comment prévenir l'infection par Hymenolepis diminuta ?\nLes animaux de compagnie peuvent-ils transmettre le parasite ?\nFaut-il éviter certains aliments pour prévenir l'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes enfants doivent-ils être surveillés pour prévenir l'infection ?",
"url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hymenolepis diminuta",
"description": "Quel est le traitement standard pour Hymenolepis diminuta ?\nLes remèdes naturels sont-ils efficaces ?\nCombien de temps dure le traitement ?\nDes effets secondaires sont-ils associés au traitement ?\nLe traitement est-il efficace à 100 % ?",
"url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hymenolepis diminuta",
"description": "Quelles complications peuvent survenir avec l'infection ?\nL'infection peut-elle entraîner des problèmes de croissance chez les enfants ?\nY a-t-il un risque de réinfection ?\nLes infections chroniques peuvent-elles causer des complications ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hymenolepis diminuta",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLes enfants sont-ils plus vulnérables ?\nLe mode de vie urbain augmente-t-il le risque ?\nLes voyages dans des pays en développement sont-ils risqués ?",
"url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Hymenolepis diminuta ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par l'examen des selles pour détecter les œufs du parasite."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'infection ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de selles répétés et éventuellement une endoscopie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des nausées et des diarrhées."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins ne sont généralement pas utiles pour diagnostiquer cette infection."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de référence pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méthode de référence est l'examen microscopique des selles pour les œufs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, diarrhée, fatigue et perte de poids."
}
},
{
"@type": "Question",
"name": "L'infection peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes peuvent être infectées sans présenter de symptômes."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus touchés par les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent présenter des symptômes plus marqués en raison de leur immunité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les signes de déshydratation, surtout en cas de diarrhée sévère."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par Hymenolepis diminuta ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une bonne hygiène, le lavage des mains et la cuisson des aliments."
}
},
{
"@type": "Question",
"name": "Les animaux de compagnie peuvent-ils transmettre le parasite ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les rongeurs peuvent être porteurs et transmettre le parasite aux humains."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments pour prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments crus ou mal cuits, surtout ceux susceptibles d'être contaminés."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où l'hygiène est insuffisante peut augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les enfants doivent-ils être surveillés pour prévenir l'infection ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants doivent être surveillés pour leur hygiène, surtout après avoir joué dehors."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour Hymenolepis diminuta ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard est l'administration de médicaments antiparasitaires comme le praziquantel."
}
},
{
"@type": "Question",
"name": "Les remèdes naturels sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de preuves solides que les remèdes naturels soient efficaces contre cette infection."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dure généralement quelques jours, selon la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Des effets secondaires sont-ils associés au traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires comme des nausées ou des douleurs abdominales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le traitement est-il efficace à 100 % ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est généralement efficace, mais des suivis sont nécessaires pour éviter les récidives."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'infection ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles digestifs graves et des carences nutritionnelles."
}
},
{
"@type": "Question",
"name": "L'infection peut-elle entraîner des problèmes de croissance chez les enfants ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'infection peut affecter la croissance et le développement des enfants."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de réinfection ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans mesures préventives, le risque de réinfection est élevé."
}
},
{
"@type": "Question",
"name": "Les infections chroniques peuvent-elles causer des complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections chroniques peuvent entraîner des complications plus graves."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent une mauvaise hygiène, le contact avec des rongeurs et des aliments contaminés."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées sont plus susceptibles de développer des infections graves."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus vulnérables en raison de leur système immunitaire en développement."
}
},
{
"@type": "Question",
"name": "Le mode de vie urbain augmente-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones urbaines avec des rongeurs peut augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les voyages dans des pays en développement sont-ils risqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des pays avec de faibles normes d'hygiène augmentent le risque d'infection."
}
}
]
}
]
}
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are post...
To evaluate the impact of an enterprise controlled substance (ECS) management system with integration of analytics software on labor requirements and inventory cost within a health-system pharmacy....
A prospective, pre-post observational study was designed to assess the impact of implementing a solution that connects disparate systems with the integration of analytics software. Three study modules...
Both of the study facilities had a decrease in CS daily stockouts and an increase in inventory turns compared to baseline, while the total number of transactions (vends) at the central vault and decen...
An inventory management system integrated with an advanced analytics tool provided a reduction in the time spent on receiving, storing, and reconciling CS records while the number of transactions incr...
Clostridium perfringens (C. perfringens) is an important pathogen that contributes to human and animal disease. At present, antibiotic therapy is one of the most effective strategies for C. perfringen...
Per- and polyfluoroalkyl substances (PFAS) are shown to have neurotoxic effects on animals, but epidemiological evidence for associations between childhood PFAS exposure and neurodevelopment is inconc...
We included 551 children 2-5 years old from the CHildhood Autism Risks from Genetics and Environment (CHARGE) case-control study. Children were clinically diagnosed and classified as having ASD, DD, O...
Childhood perfluorooctanoic acid (PFOA) was associated with increased odds of ASD (odds ratio [OR] per ln ng/mL increase: 1.99, 95% confidence interval [CI]: 1.20, 3.29) and DD (OR: 2.16, 95% CI: 1.21...
In this case-control study, childhood PFOA, PFHpA, and a PFAS mixture was associated with increased odds of ASD, while PFUnDA was associated with decreased odds of ASD. Because we used concurrent meas...
Substance use disorder (SUD) is a complex disease involving nontrivial biological, psychological, environmental, and social factors. While many mathematical studies have proposed compartmental models ...
New psychoactive substances (NPS) are substances of abuse that easily evade existing controlled drug regulations. This study conducted a systematic review on controlled drug regulations and analyzed t...
Individuals with substance use problems show lower executive control and alterations in prefrontal brain systems supporting emotion regulation and impulse control. A separate literature suggests that ...
The role of perfluoroalkyl and polyfluoroalkyl substances (PFAS) as thyroid carcinogens is unclear. Therefore, we intended to identify associations between each PFAS congener and their mixture with th...
Substance Use Disorders (SUDs) present a significant challenge to global public health, with prolonged drug use not only impairing individual health but also hindering social development. Despite vari...
Perfluoroalkyl substances (PFAS) are environmental contaminants present in a wide range of consumer products and frequently detected in drinking water. They have been linked to adverse reproductive he...
To explore the association between plasma concentrations of several PFAS, considered individually and as a mixture, and the risk of endometriosis in women of childbearing age....
Between 2018 and 2020, 42 patients with endometriosis and 90 controls undergoing abdominal surgery were recruited at two public hospitals in Granada, Spain. The presence or absence of endometriosis wa...
In models adjusted for age, schooling, and parity, perfluorotridecanoic acid (PFTrDA) was associated with higher odds of endometriosis (odds ratio [OR] = 1.74; 95 % CI = 1.11-2.73 per 2-fold increase ...
These findings suggest that exposure to certain PFAS may increase the odds of endometriosis. However, given the modest sample size, further studies are warranted to verify these results....
Theories of addiction posit a deficit in goal-directed behavior and an increased propensity toward habitual actions in individuals with substance use disorders. Control over drug intake is assumed to ...